Cas:35418-07-6 Methyl 3-(4-aminophenyl)propanoate manufacturer & supplier

Chemical Name:Methyl 3-(4-aminophenyl)propanoate

CAS.NO:35418-07-6

Synonyms:4-[2-(methoxycarbonyl)-ethyl]-aniline;3-(p-Aminophenyl)-propansaeuremethylester;methyl p-aminophenylpropanoate;3-(4-aminophenyl)propionic acid methyl ester;methyl 3-(4-amino-phenyl)-propionate

Molecular Formula:C₁₀H₁₃NO₂

Molecular Weight:179.21600

HS Code:2922499990

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:52.32000

Exact Mass:179.09500

LogP:1.95560

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-[2-(methoxycarbonyl)-ethyl]-aniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 3-(4-amino-phenyl)-propionate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 3-(4-amino-phenyl)-propionate Use and application,4-[2-(methoxycarbonyl)-ethyl]-aniline technical grade,usp/ep/jp grade.

Related News: Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. Methyl 3-(4-aminophenyl)propanoate manufacturer Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. Methyl 3-(4-aminophenyl)propanoate supplier Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. Methyl 3-(4-aminophenyl)propanoate vendor Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies. Methyl 3-(4-aminophenyl)propanoate factory Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.